Conditions such as obesity and non-alcoholic fatty liver disease (NAFLD) are associated with a lower expression and activity of CYP3A4, and several studies suggest that body weight is inversely associated with CYP3A4 activity [5–10]. The gene discussed is CYP3A4; the disease is metabolic dysfunction-associated steatotic liver disease.